glp-1 gip therapy effectiveness muscle loss Study finds receptor agonists target fat over for weight TrimRX | GLP-1 vs GIP:

And then we formulated something that isnt just supportiveits strategic

Unlike traditional interventions such as low-calorie diets or behavioral counseling, which often result in 30% weight regain within one year, pharmacologic agents like semaglutide and tirzepatide have demonstrated durable weight reductions of 10-20%, alongside improvements in cardiometabolic risk factors, such as blood pressure, HbA1c, and lipid profiles

5, A393

Los cambios en el estado cardiovascular o desarrollo de contraindicaciones especficas (como historia personal de carcinoma medular de tiroides o neoplasia endocrina mltiple tipo 2 para ciertos agonistas GLP-1) requieren reevaluacin del tratamiento

J Biol Chem 265: 20259-20262, 1990